Source comparison
Rotate Melanotan-1 Injection Sites: Comparison
No rotation (same site daily) N/A. Continuous trauma 85–95% develop visible nodules Drops 40–60% within 3 weeks Simplest short-term Unacceptable. Guaranteed tissue damage and absorption failure by week 4 Two-site alternation (e.g., left/right abdomen) 48 hours
This comparison does not assign a generated winner or score.
- No rotation (same site daily)
- N/A. Continuous trauma
- 85–95% develop visible nodules
- Drops 40–60% within 3 weeks
- Simplest short-term
- Unacceptable. Guaranteed tissue damage and absorption failure by week 4
- Two-site alternation (e.g., left/right abdomen)
- 48 hours between same-site use
- 60–70% develop nodules
- Inconsistent. Ranges 50–85%
- Low. Easy to remember
- Insufficient recovery time. Inflammation compounds faster than resolution
- Four-zone rotation (14-day minimum)
- 14 days per site
- 8–12% develop nodules
- Stable 85–92% across cycles
- Moderate. Requires tracking
- Gold standard. Balances tissue preservation with practical site availability
- Eight-zone rotation (21-day minimum)
- 21 days per site
- <5% develop nodules
- Optimal 88–94%
- High. Complex tracking needed
- Ideal for long-term protocols but unnecessary for cycles under 12 weeks